Medicinal plants rediscovered

Seminars in Anesthesia

Volumn 17, Issue 4, 1998, Pages 319-330

  Gillis, C N ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ECHINACEA PURPUREA EXTRACT; GINKGO BILOBA EXTRACT; HYPERICUM PERFORATUM EXTRACT; VALERIAN;

ARTICLE; DRUG EFFICACY; DRUG SAFETY; GINSENG; HERBAL MEDICINE; MEDICINAL PLANT; PRIORITY JOURNAL; SABAL; TANACETUM PARTHENIUM; TRADITIONAL MEDICINE; UNITED STATES;

EID: 0032411538     PISSN: 02770326     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0277-0326(98)80029-9     Document Type: Article

References (84)

1. Akerele O WHO guidelines for the assessment of herbal medicines Fitoterapia 62 1992 99 110
2. Parnam MJ Benefit-risk assessment of the squeezed sap of the purple coneflower ( Echinaceae purpurea ) for long-term oral immunostimulation Phytomedicine 3 1996 95 102
3. Roesler J Emmendorffer A Steinmuller C Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea to test subjects mediates activation of the phagocyte system Int J Immunopharmacol 13 1991 931 941
4. Tyler VE Herbs of Choice The Therapeutic Use of Phytomedicinals 1994 Pharmaceutical Products Press New York, NY
5. Linde K Ramirez CD Mulrow CD St John's wort for depression—An overview and meta-analysis of randomized clinical trials BMJ 313 1996 253 258
6. Plosker GL Brogden RN Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia Drugs Aging 9 1996 379 395
7. Murphy JJ Heptinstall S Mitchell JR Randomized double-blind placebo-controlled trial of feverfew in migraine prevention Lancet 2 1988 189 192
8. Gillis CN Panax ginseng pharmacology: A nitric oxide link? Biochem Pharmacol 54 1997 1 8
9. LeBars PL Katz MM Berman N A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia JAMA 278 1997 1327 1332
10. Leathwood PD Chauffard F An aqueous extract of valerian reduces latency to fall asleep in man Planta Med 2 1985 144 148
11. Lindahl O Lindwall L Double-blind study of a valarian preparation Pharmacol Biochem Behav 32 1989 1065 1066
12. Schulz H Stolz C Muller J The effect of valerian extract on sleep polygraphy in poor sleepers: A pilot study Pharmacopsychiatry 27 1994 147 151
13. Johnston BA Market report: One third of nation's adults use herbal remedies HerbalGram 40 1997 49
14. Jonas WB Researching alternative medicine Nat Med 3 1997 824 827
15. Blumenthal M Goldberg A Gruenwald J The German Commission E Monographs: Therapeutic Monographs on Medicinal Plants for Human Use 1998 American Botanical Council Austin, TX 685
16. Keller K Herbal medicinal products in Germany and Europe: Experiences with national and European assessment Drug Information J 30 1996 933 948
17. Johnston BA Natural herbal products sales HerbalGram 40 1997 52
18. Marwick C Growing use of medicinal botanicals forces assessment by drug regulators JAMA 273 1995 607 609
19. Huxtable R The myth of beneficent nature: The risks of herbal preparations Ann Intern Med 117 1992 165 166
20. Upton R St. John's Wort: Quality Control, Analytical and Therapeutic Monograph 1997 American Herbal Pharmacopoeia Santa Cruz, CA
21. (editorial) DeSmet PAGM Nolan WA St John's wort as antide-pressant BMJ 313 1996 241 242
22. Cott JM In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract Pharmacopsychiatry 30 1997 108 112
23. Staffeldt B Kerb R Brockmoller J Pharmacokinetics of hypericin and pseudohypericin after local intake of the Hypericum perforatum extract LI 160 in healthy volunteers J Geriatr Psychiatry Neurol 7 suppl 1 1994 S47 S53
24. (in press) Cott JM Misra R Medicinal plants: A potential source of new psychotherapeutic drugs Kanba S Richelson SE New Drug Development From Herbal Medicines in Neuropsychopharmacology vol 5 1998 Brunner/Mazel New York, NY
25. Butterweck V Wall A Lieflandes-Wolf U Effect of the total extract and fractions of Hypericum perforatum in Pharmacopsychiatry 30 suppl 2 1997 129 134
26. (suppl) Harrer G Hubner W-D Podzuweit H Effectiveness and tolerance of the Hypericum extract LI 160 in comparison with imipramine: Randomized double blind study with 135 outpatients J Geriatr Psychiatry Neurol 7 1994 S24 S28
27. (suppl) Martinez B Kasper S Ruhrman S Hypericum in the treatment of seasonal affective disorders J Geriatr Psychiatry Neurol 7 1994 S29 S33
28. Woelk H Burkard G Grunwald J Benefits and risks of the Hypericum extract LI 160: Drug monitoring study with 3250 patients J Geriatr Psychiatry Neurol 7 1994 S34 S38
29. Hoffert SP: Efforts increase to boost validity of metanalysis, in The Scientist. January 5, 1998, p 7
30. Stephenson J Saint John's wort study launched JAMA 278 1997 1563
31. McGuffin M Hobbs C Upton R Botanical Safety Handbook American Herbal Products Association 1997 CRC Press Boca Raton, FL
32. Ramassamy C Girbe F Christen Y Ginkgo biloba extract EGb 761 or trolox C prevent the ascorbic acid/Fe2+ induced decrease in synaptosomal membrane fluidity Free Radic Res Commun 19 1993 341 350
33. Chen X Salwinski S Lee TJ Extracts of Ginkgo biloba and ginsenosides exert cerebral vasorelaxation via a nitric oxide pathway Clin Exp Pharmacol Physiol 24 1997 958 959
34. Marcocci L The nitric oxide scavenging properties of Ginkgo biloba extract EGb 761 Biochem Biophys Res Commun 201 1994 748 755
35. Kobuchi H LDroy-Lefaix MT Christen Y Ginkgo biloba extract (EGb 761): Inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7 Biochem Pharmacol 53 1997 897 903
36. Braquet P BN 52021 and related compounds: A new series of highly specific PAF-Acether receptor antagonists isolated from Ginkgo biloba Blood Vessels 16 1985 559 572
37. Braquet P Bourgain RH Anti-anaphylactic properties of BN 52021: A potent platelet activating factor antagonist Adv Exp Med Biol 215 1987 215 233
38. Maitra I Marcocci L Droy-Iefaix MT Peroxyl radical scavenging activity of Gingko biloba extract EGb761 Biochem Pharmacol 49 1995 1649 1655
39. Noda Y Anzai K Mori A Hydroxyl and superoxide anion radical scavenging activities of natural source antioxidants using the computerized JES-FR30 ESR spectrometer system Biochem Mol Biol Int 42 1997 35 44
40. Lee SL Wang WW Lanzillo J Superoxide scavenging effect of Ginkgo biloba extract on seratonin-induced mitogenesis Biochem Pharmacol 56 1998 527 533
41. Mouren X Caillard PH Schwartz F Study of the antiischemic action of EGb 761 in the treatment of peripheral arterial occlusive disease by TcPO2 detemrination Angiology 45 1994 413 417
42. Itil T Martorano D Natural substances in psychiatry ( Ginkgo biloba in dementia) Psychopharmacol Bull 31 1995 147 158
43. Pietri S Seguin JR d'Arbigny P Ginkgo biloba extract (EGb 761) pretreatment limits free radical-induced oxidative stress in patients undergoing coronary bypass surgery Cardiovasc Drugs Ther 11 1997 121 131
44. Bauer R Wagner H Echinaceae species as potential immunostimulatory drugs Nagner H Farnsworth NR Economic and Medicinal Plant Research vol 5 1991 Academic New York, NY 253 322
45. (suppl) Hobbs C Echinaceae: A literature review HerbalGram 30 1994 34 48
46. Foster S Echinacea : The Purple Coneflowers 1990 American Botanical Council Austin, TX
47. Luettig B Steinmuller C Gifford GE Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea J Natl Cancer Inst 81 1989 669 675
48. Brown AM Edwards CM Davey MR Pharmacological activity of feverfew ( Tanacetum parthenium (L.) Schultz-Bip.): Assessment by inhibition of human polymorphonuclear leukocyte chemiluminescence in-vitro J Farm Pharmacol 49 1997 558 561
49. Awang D Feverfew trials: The promise of—and the problem with—standardized botanical extract HerbalGram 41 1997 16 17
50. Awang DVC Dawson BA Kindack DG Parthenolide content of feverfew ( Tancetum parthenium ) by HPLC and NMR J Nat Prod 154 1991 1516 1521
51. Fozard JR 5-Hydroxytryptamine in the pathophysiology of migraine Bevan JA Vascular Neuroeffector Mechanisms 1985 Elsevier Amsterdam, The Netherlands 321 328
52. Groenewegen WA Heptinstall S A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro J Pharm Pharmacol 42 1990 553 557
53. Makheja AN Bailey JM A platelet phospholipase inhibitor from the medicinal herb feverfew ( Tanacetum parthenium ) Prostaglandins Leukot Med 8 1982 653 660
54. Barsby RW Salan U Knight DW Feverfew and vascular smooth muscle: Extracts from fresh and dried plants show opposing pharmacological profiles, dependent upon sesquiterpene lactone content Planta Med 59 1993 20 25
55. Hay AJ Hamburger M Hostettmann K Toxic inhibition of smooth muscle contractility by plant-derived sesquiterpenes caused by their chemically reactive α-methylenebutyrolactone functions Br J Pharmacol 112 1994 9 12
56. Johnson ES Kadam NP Hylands DM Efficacy of feverfew as prophylactic treatment of migraine BMJ 291 1985 569 573
57. USP Open Conference Information issues—draft proposals for valerian and ginger 1996 USP Pharmacopeial Convention Washington, DC 335 372
58. Leuschner J Muller J Rudmann M Characterisation of the central nervous depressant activity of a commercially available valerian root extract Arzneimittelforschung 43 1993 638 641
59. Andreatini R Leite JR Effect of valepotriates on the behavior of rats in the elevated plus-maze during diazepam withdrawal Eur J Pharmacol 260 1994 233 235
60. Leathwood PD Chauffard F Quantifying the effects of mild sedatives J Psychiatr Res 17 1983 115 122
61. Santos MS Ferreira F Cunha AP Synaptosomal GABA release as influenced by valerian root extract—Involvement of the GABA carrier Arch Int Pharmacodyn Ther 327 1994 220 231
62. Brekhman II Dardymov IV New substances of plant origin which increase nonspecific resistance Ann Rev Pharmacol 9 1969 419 430
63. Liberti L Marderosian AD Evaluation of commercial ginseng products J Pharm Sci 67 1978 1487 1489
64. Bahrke MS Morgan WP Evaluation of ergogenic properties of ginseng Sports Med 18 1994 229 248
65. Pieralisi G Ripar P Veechiet L Effects of a standardized ginseng extract combined with dimethylaminoethanol bitartrate, vitamins, minerals and trace elements on physical performance during exercise Clin Ther 13 1991 373 382
66. D'Angelo L Grimaldi R Caravaggi M A double-blind, placebo controlled clinical study on the effect of a standardized ginseng extract on psychomotor performance in healthy volunteers J Ethnopharmacol 16 1986 15 22
67. Wiklund I Carlsberg J Lund B A double-blind comparison of the effect on quality of life of a combination of vital substances including standardized ginseng G115 and placebo Curr Ther Res 55 1994 32 42
68. Fulder SJ Ginseng and the hypothalamic-pituitary control of stress Am J Chinese Med 9 1981 112 118
69. Jie JH Cammisuli S Baggiolini M Immunomodulatory effects of Panax Ginseng C.A. Meyer in the mouse Agents Actions 15 1984 386 391
70. Tachikawa E Kudo K Kashimoto T Ginseng saponins reduce acetylcholine-evoked Na+ influx and catecholamine secretion in bovine adrenal chromaffin cells J Pharmacol Exp Ther 273 1995 629 636
71. Chen X Cardiovascular effects of ginsenosides and their nitric oxide-mediated antioxidant action Packer L Traber MG Xin W Proceedings of the International Symposium on Natural Antioxidants 1996 AOCS Champaign, IL 179 187
72. Rimar S Lee-Mengel M Gillis CN Pulmonary protective and vasodilator effects of a standardized panax ginseng preparation following artificial gastric digestion Pulm Pharmacol 9 1996 205 209
73. Zhan Y Xu XH Jiang YP Effects of ginsenosides on myocardial ischemia/reperfusion damage in open heart surgery patients Chung Hua I Hsueh Tsa Chih (Med J China) 74 1994 626 628
74. Kang SY Schini-Kerth VB Kim ND Ginsenosides of the protopanaxatriol group cause endothelium-dependent relaxation in the rat aorta Life Sci 56 1995 1577 1586
75. Han SW Kim H Ginsenosides stimulate endogenous production of nitric oxide in rat kidney Int J Biochem Cell Biol 28 1996 573 580
76. Bush PA Aronson WJ Buga GM Nitric oxide is a potent relaxant of human and rabbit corpus cavernosum J Urol 147 1992 1650 1655
77. Rajfer J Aronson WJ Bush PA Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to non-adrenergic, noncholinergic neurotransmission N Engl J Med 326 1992 90 94
78. Chen X Lee TJ Ginsenosides-induced nitric oxide-mediated relaxation of the rabbit corpus cavernosum Br J Pharmacol 115 1995 15 18
79. Cui J Garle M Eneroth P What do commercial ginseng preparations contain? Lancet 344 1994 9
80. Seigal RK Ginseng abuse syndrome JAMA 241 1979 1614 1615
81. Genest K Hughes DW Natural products in Canadian Pharmaceuticals IV Hydrastis canadensis Can J Pharm Sci 4 1969 41 45
82. Bannerman JE Goldenseal in world trade: Pressures and potentials HerbalGram 41 1997 51 52
83. Lehle C Delos S Guirou O Human prostatic steroid 5 alpha-reductase isoforms—a comparative study of selective inhibitors J Steroid Biochem Mol Biol 54 1995 273 279
84. McConnell JD Bruskewitz R Walsh P The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia N Engl J Med 338 1998 557 563